Cempra (CEMP:NAS) and Ophthotech (OPHT:NAS) Trading at Less than Cash Value

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Trading at Less than Cash Value

Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.

What this Means…

Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.

Today’s Data on NASDAQ

Today’s data is for companies listed on the NASDAQ.

Symbol Name Close Price Shares Outstanding P/E P/B Cash per Share Net Cash per Share
XNET Xunlei Ltd 3.270000 66183450 None 0.5961 3.69 None
CEMP Cempra Inc 3.850000 52503483 None 1.2415 3.86 3.60
OPHT Ophthotech Corp 2.540000 35942879 None None 3.92 5.86
MLNK ModusLink Global Solutions Inc 1.620000 55554589 None 1.2895 2.02 0.96
GURE Gulf Resources Inc 1.800000 46793791 2.2840 0.2407 3.69 3.64
SRRA Sierra Oncology Inc 1.500000 52268443 None 0.6559 2.39 0.46
UTSI UTStarcom Holdings Corp 2.120000 36460201 None 0.8085 2.23 8.49
CXRX Concordia International Corp 1.400000 51089782 None None 6.58 -62.94
APWC Asia Pacific Wire & Cable Corp Ltd 3.050000 13819669 14.5238 0.3100 3.49 1.44
JRJC China Finance Online Co Ltd 1.500000 23619603 None 0.5542 1.87 1.54
VLRX Valeritas Holdings Inc 5.350000 6842978 3.8936 1.2820 7.48 2.64
OREX Orexigen Therapeutics Inc 2.370000 15227802 None 0.8756 5.03 -6.60
GIGM GigaMedia Ltd 3.050000 11052235 None 0.5554 6.01 5.77
EVK Ever-Glory International Group Inc 2.450000 14792836 4.0909 0.3945 4.06 1.89
PRPH ProPhase Labs Inc 2.040000 16159796 2.3837 0.6538 2.65 2.65
ZAIS ZAIS Group Holdings Inc 2.110000 14680782 None 0.7886 3.05 -23.63
ATEC Alphatec Holdings Inc 1.710000 10857733 None None 2.35 -1.58
ABAC Aoxin Tianli Group Inc 2.230000 7983745 14.6667 0.2118 7.08 6.75
CBIO Catalyst Biosciences Inc 3.870000 4310561 None 0.5256 7.51 6.18
GLBR Global Brokerage Inc 1.900000 6143305 0.8864 None 85.35 58.77
ACHV Achieve Life Sciences Inc 4.157300 2736769 None 0.8146 5.08 5.06
ROSG Rosetta Genomics Ltd 1.600000 2588148 None 0.9785 2.38 0.91
MDGS Medigus Ltd 2.080000 1992571 None 1.1003 4.23 None
KBSF KBS Fashion Group Ltd 2.510000 1772016 None 0.0458 13.49 12.01
TOPS TOP Ships Inc 1.890000 288002 None 0.0075 5.52 -359.73

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

CEMP:NAS Cempra

http://www.cempra.com
Cempra has 45 employees and is headquartered in United States.
Cempra Inc is a biotechnology company which develops differentiated antibiotics for acute care and community settings. Its goal is to develop treatments for bacterial infectious diseases, mainly respiratory tract infections and staphylococcal infections.

OPHT:NAS Ophthotech

http://www.ophthotechinc.com
Ophthotech has 156 employees and is headquartered in United States.
Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of the back of the eye.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.